Balloon Pump Assisted Coronary Intervention Study

Balloon Pump Assisted Coronary Intervention Study

This study will test the hypothesis that elective use of the Intra-Aortic Balloon Pump (IABP) in patients undergoing high-risk Percutaneous Coronary Intervention (PCI) will reduce the rate of in-hospital major adverse cardiac and cerebrovascular events compared to patients who are managed without planned insertion of IABP.

Inclusion Criteria:

• impaired left ventricular function (Ejection Fraction < 30%)
• large area of myocardium at risk (BCIS-1 Myocardial Jeopardy Score ≥ 8/12)

Exclusion Criteria:

• cardiogenic shock
• acute STEMI within previous 48 hours
• complications of recent AMI (including ventricular septal defect, severe mitral regurgitation, intractable ventricular arrhythmias)
• contraindications to IABP use (including significant iliac or femoral arterial disease and more than mild aortic regurgitation)